Chemo Espana SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile
July 2017
37
About the Report
About the Report
Summary
Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics in different formulations such as tablets, capsules, injectables and suspensions. The company's target therapy areas include cardiovascular, gastroenterology, anti-infective, central nervous system, respiratory, women's healthcare, endocrinology, dermatology and urology. Chemo Group's OTC division develops food supplements in the form of soft gel capsules, hard capsules, tablets, pellets, sachets to cosmetics covering metabolic syndrome, digestive disorders, women and men healthcare, weigh control or quality of life. It has presence in Europe, South America, Asia and North America. Chemo Group is headquartered in Madrid, Spain.
Chemo Espana SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Chemo Espana SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Chemo Espana SA, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Exeltis Acquires Juste Farma Division from Juste labs 14
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 14
Partnerships 16
mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 16
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 16
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 17
GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 18
Licensing Agreements 19
Exeltis Enters into Licensing Agreement with Neurim Pharma 19
Chemo Enters into Licensing Agreement with IntelGenx 20
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 20
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 21
Acquisition 22
Exeltis Acquires Embil Pharma 22
mAbxience Acquires GH Genhelix for USD13.5 Million 23
Exeltis Acquires Althea Pharma 23
Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 24
Chemo Espana Acquires 75% Stake In Nufarindo 25
Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 26
Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 27
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 28
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 28
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 29
Chemo Espana SA-Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 36
Legal and Regulatory 36
Jan 07, 2016: Chemo renews the ISO 14001 environmental certificate of its Laboratorios Liconsa pharmaceutical plant in Azuqueca de Henares 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11
List of Table
List of Tables
Chemo Espana SA, Pharmaceuticals & Healthcare, Key Facts 1
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Chemo Espana SA, Deals By Therapy Area, 2011 to YTD 2017 9
Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Exeltis Acquires Juste Farma Division from Juste labs 14
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 14
mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 16
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 16
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 17
GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 18
Exeltis Enters into Licensing Agreement with Neurim Pharma 19
Chemo Enters into Licensing Agreement with IntelGenx 20
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 20
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 21
Exeltis Acquires Embil Pharma 22
mAbxience Acquires GH Genhelix for USD13.5 Million 23
Exeltis Acquires Althea Pharma 23
Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 24
Chemo Espana Acquires 75% Stake In Nufarindo 25
Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 26
Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 27
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 28
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 28
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 29
Chemo Espana SA, Key Competitors 31
Chemo Espana SA, Key Employees 32
Chemo Espana SA, Other Locations 33
Chemo Espana SA, Subsidiaries 34
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.